- Forums
- ASX - By Stock
- Ann: Quarterly Appendix 5B Cash Flow Report - March 2024
No money spent on exploration, just $1.5 m left lovely!
Featured News
Add TMR (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.655M |
Open | High | Low | Value | Volume |
0.5¢ | 0.5¢ | 0.5¢ | $14.10K | 2.820M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
24 | 5994121 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 4906059 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
24 | 5994121 | 0.004 |
11 | 9590003 | 0.003 |
7 | 14250101 | 0.002 |
8 | 36100102 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 4906059 | 1 |
0.006 | 4289350 | 8 |
0.007 | 2841084 | 6 |
0.008 | 2025500 | 2 |
0.009 | 1011140 | 2 |
Last trade - 11.09am 06/05/2024 (20 minute delay) ? |
|
|||||
Last
0.5¢ |
  |
Change
0.000 ( 0.00 %) |
|||
Open | High | Low | Volume | ||
0.5¢ | 0.5¢ | 0.5¢ | 1805520 | ||
Last updated 12.22pm 06/05/2024 ? |
Featured News
TMR (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online